Home > Riviste > Minerva Gastroenterology > Fascicoli precedenti > Articles online first > Minerva Gastroenterology 2021 Apr 01

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Minerva Gastroenterology 2021 Apr 01

DOI: 10.23736/S2724-5985.21.02853-1

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Breakdown in hepatic tolerance and its relation to autoimmune liver diseases

Amber BOZWARD 1, 2, Maurizio CÈ 3, Liliana DELL'ORO 4, Ye H. OO 1, 2, 5, Vincenzo RONCA 1, 2, 5

1 Centre for Liver and Gastro Research and NIHR Biomedical Research Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; 2 Centre for Rare Diseases, European Reference Network Centre- Rare Liver, Birmingham, UK; 3 Dipartimento di Scienze della Salute, Università degli studi di Milano, Milano, Italy; 4 School of Medicine, Università degli studi di Milano-Bicocca, Milan, Italy; 5 Liver Transplant and Hepatobiliary Unit, University Hospital of Birmingham NHS Foundation Trust, Birmingham, UK


PDF


The liver is a complex immunological organ. It has both immunogenic and tolerogenic capacity. Tolerogenic potential of human liver with its protective firewalls is required to guard the body against the continuous influx of microbial product from the gut via the sinusoids and biliary tree. Immunotolerance and anergic state is maintained by a combined effort of both immune cells, parenchyma cells, epithelial and endothelial cells. Despite this, an unknown trigger can ignite the pathway towards breakdown in hepatic tolerance leading to autoimmune liver diseases. Understanding the initial stimulus which causes the hepatic immune system to switch from the regulatory arm towards self-reactive effector arm remains challenging. Dissecting this pathology using the current technological advances is crucial to develop curative immune based therapy in autoimmune liver diseases. We discuss the hepatic immune cells and non-immune cells which maintain liver tolerance and the evidence of immune system barrier breach which leads to autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis.


KEY WORDS: Liver immunology; Immunotolerance; Autoimmune liver diseases; Autoimmunity

inizio pagina